Monday, 5 December 2011
Epilepsy Canada Announces Board of Directors Changes
New Board Members:
We are very pleased to announce that Epilepsy Canada has elected two new directors to complement our dynamic leadership team. Joining the Epilepsy Canada Board are AnneMarie Ryan and Jacques Brunelle.
AnneMarie Ryan is President of AMR Associates and Chair of WCM (Women in Capital Markets). AnneMarie consults to Canadian Financial services firms on market structure and how technology is transforming the investment business. AnneMarie has over 25 years consulting in the Financial Services industry working with ITG Canada, Ontario Securities Commission, Canaccord Capital, Perimeter Financial, and eTrade Canada to name a few. In addition AnneMarie sits on the boards of Benefaction and TriAct Canada Marketplace LLP.
AnneMarie holds a Bachelor of Arts Degree in Political Science and MBA from the University of Toronto.
Jacques Brunelle is Vice President, Business Development at INFORMAT Software Inc. in Montreal, Quebec. Jacques has over 30 year’s business experience in business having worked with IBM Canada, Canada Post, Van Houtte, McKesson Canada, and Uniprix Pharmacies. Jacques has been involved with various foundations such as Ressources Jeunesse, The Terry Fox Foundation, and the F.I.N.L.B. (for the visually impaired).
Jacques holds a Bachelor of Commerce Degree from McGill. Jacques also coaches a children’s ski racing program at Mount Tremblant and is involved in organizing two National Tennis Championship tournaments (under 12, under 14).
Changes to Existing Board Member Status:
Dr. W. McIntyre (Mac) Burnham, Department of Pharmacology at the University of Toronto, has been elected President and Gary Collins, Managing Partner of 4Growth Inc., Vice President of Epilepsy Canada.
Dr. Donald Weaver becomes Past- President, Board Member.
Epilepsy Canada is stronger than ever with this new leadership team in place.
We look forward to being the most formative body in Canada to lead RESEARCH in this field.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment